How accurate is the Clairity Breast Cancer 5-Year Risk Assessment?

Clairity Breast was tested on more than 250,000 mammograms in women across the US and Europe and is the first FDA authorized AI-driven software to assess breast cancer risk in women with a screening mammogram.¹ ² ³

You should review your result with your provider, rather than interpreting it alone, so they can consider this risk score and your full health profile to determine any additional screening steps that may be right for you. Clairity Breast scores greater than 5% should be interpreted with caution. While all scores greater than 5% are considered high risk, high-risk scores produced by the model may tend to significantly overestimate risk, particularly scores above 10%.

Full Clairity Breast disclosures are available here.